Regeneron Pharmaceuticals, Inc.
Adenylate Cyclase 7 (ADCY7) Variants And Uses Thereof

Abstract:

The present disclosure provides methods of treating subjects having an interferon mediated disease, methods of identifying subjects having an increased risk of developing an interferon mediated disease, and methods of detecting human Adenylate Cyclase 7 (ADCY7) variant nucleic acid molecules and variant polypeptides.